Patti Beadles
unread,Sep 21, 2021, 4:07:04 AM9/21/21Sign in to reply to author
Sign in to forward
You do not have permission to delete messages in this group
Either email addresses are anonymous for this group or you need the view member email addresses permission to view the original message
to barge-...@barge.org
From your own link:
“There is no ivermectin-specific order from the Board. The situation you describe is a pharmacist appropriately intervening to reject a script that is not clinically indicated for a diagnosed condition. Departments of Health and Boards of Pharmacy across the nation have developed strategies to address the problem of unproven and often dangerous therapies proposed for COVID-19 treatment or prevention.
“Prescribers were asked to not prescribe unproven therapies, and the Director issued an Act 91 directive reminding pharmacists to perform enhanced drug utilization reviews (DURs): determining the safety and therapeutic appropriateness of a prescribed drug for a diagnosed condition. A DUR is standard pharmacist care. When a hazardous or illegitimate script is presented, a pharmacist is expected to use their professional judgment to intervene on behalf of the patient. That can include refusing the prescription.”
Also:
The American Medical Association (AMA), American Pharmacists Association (APhA), and American Society of Health-System Pharmacists (ASHP) strongly oppose the ordering, prescribing, or dispensing of ivermectin to prevent or treat COVID-19 outside of a clinical trial.
Do you object to medical professionals following medical ethics guidlines, Quick?
-P